Crossmark

Efficacy and safety of a new insulin infusion protocol adapted for the target glycemic range of 140–180 mg/dl in adult critical care units: a tertiary care centre experience

Crossref DOI link: https://doi.org/10.1007/s13410-020-00915-3

Published Online: 2021-01-08

Published Print: 2021-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Masood, Muhammad Qamar

Batool, Sumera

Banu, Sabiha

Hussain, Erfan
License Information

Text and Data Mining valid from 2021-01-08

Version of Record valid from 2021-01-08
More Information

Article History

Received: 15 April 2020

Accepted: 23 December 2020

First Online: 8 January 2021

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: This study was approved by the ethical review committee of our institution and throughout the study, core ethical principles of research were followed.

: Not applicable.

Document is current

Any future updates will be listed below